APA (7th ed.) Citation

Cuccia, F., Mazzola, R., Figlia, V., Rigo, M., Nicosia, L., Giaj-Levra, N., . . . Alongi, F. (2021). PO-1388 1.5 T MR-guided SBRT for oligorecurrent prostate cancer: Preliminary report of feasibility and PROMs. Radiotherapy & Oncology, 161, S1138. https://doi.org/10.1016/S0167-8140(21)07839-7

Chicago Style (17th ed.) Citation

Cuccia, F., et al. "PO-1388 1.5 T MR-guided SBRT for Oligorecurrent Prostate Cancer: Preliminary Report of Feasibility and PROMs." Radiotherapy & Oncology 161 (2021): S1138. https://doi.org/10.1016/S0167-8140(21)07839-7.

MLA (9th ed.) Citation

Cuccia, F., et al. "PO-1388 1.5 T MR-guided SBRT for Oligorecurrent Prostate Cancer: Preliminary Report of Feasibility and PROMs." Radiotherapy & Oncology, vol. 161, 2021, p. S1138, https://doi.org/10.1016/S0167-8140(21)07839-7.